Robert J. Nichols

1.2k total citations
22 papers, 387 citations indexed

About

Robert J. Nichols is a scholar working on Molecular Biology, Biotechnology and Oncology. According to data from OpenAlex, Robert J. Nichols has authored 22 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Biotechnology and 4 papers in Oncology. Recurrent topics in Robert J. Nichols's work include Protein Tyrosine Phosphatases (8 papers), Cancer Research and Treatments (4 papers) and Galectins and Cancer Biology (4 papers). Robert J. Nichols is often cited by papers focused on Protein Tyrosine Phosphatases (8 papers), Cancer Research and Treatments (4 papers) and Galectins and Cancer Biology (4 papers). Robert J. Nichols collaborates with scholars based in United States, Taiwan and Spain. Robert J. Nichols's co-authors include Elizabeth E. Howell, Richard C. Ogden, Mallika Singh, Jacqueline A.M. Smith, Adrian L. Gill, Elena S. Koltun, David Wildes, Justin P. Annes, Christopher J. Schulze and Ping Zhuang and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Cancer Research.

In The Last Decade

Robert J. Nichols

21 papers receiving 381 citations

Peers

Countries citing papers authored by Robert J. Nichols

Since Specialization

Citations

This map shows the geographic impact of Robert J. Nichols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Nichols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Nichols more than expected).

Fields of papers citing papers by Robert J. Nichols

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Nichols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Nichols. The network helps show where Robert J. Nichols may publish in the future.

Co-authorship network of co-authors of Robert J. Nichols

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Nichols. A scholar is included among the top collaborators of Robert J. Nichols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Nichols. Robert J. Nichols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 3595: RMC-6291, a next-generation tri-complex KRASG12C(ON) inhibitor, outperforms KRASG12C(OFF) inhibitors in preclinical models of KRASG12C cancers 2022 ·Cancer Research ·Robert J. Nichols, Yu Chi Yang, Jim Cregg, (unknown), Zhican Wang, Richa Dua, Jingjing Jiang, Lindsay S. Garrenton, Nicole Nasholm, Alun Bermingham, John E. Knox, Kyle J. Seamon, (unknown), Kang-Jye Chou, Shaoling Li, David Wildes, Mallika Singh, Elena S. Koltun, Adrian L. Gill, Jacqueline A.M. Smith	27
2	Allosteric Inhibition of SHP2 Stimulates Antitumor Immunity by Transforming the Immunosuppressive Environment 2020 ·Cancer Research ·Elsa Quintana, Christopher J. Schulze, Darienne R. Myers, Tiffany J. Choy, Kasia Mordec, David Wildes, (unknown), (unknown), Elena S. Koltun, Adrian L. Gill, Mallika Singh, Stephen M. Kelsey, Mark A. Goldsmith, Robert J. Nichols, Jacqueline A.M. Smith	69
3	Abstract LB-113: Positioning a selective, bi-steric inhibitor of mTORC1 as a combination partner in RAS-driven cancers 2020 ·Cancer Research ·Yu Chi Yang, Christopher J. Schulze, Jingjing Jiang, (unknown), Tiffany J. Choy, (unknown), Zhican Wang, Dong Hun Lee, Robert J. Nichols, Zhengping Wang, Jacqueline A.M. Smith, (unknown), Mallika Singh	1
4	Abstract 1943: SHP2 inhibition as the backbone of targeted therapy combinations for the treatment of cancers driven by oncogenic mutations in the RAS pathway 2020 ·Cancer Research ·Jacqueline A.M. Smith, Mallika Singh, Robert J. Nichols, Elena S. Koltun, Yu Chi Yang, David Wildes, Carlos Stahlhut, Dong Hun Lee, (unknown), (unknown), Abby Marquez, Grace J. Lee, Shaoling Li, Christophe Marcireau, Laurent Debüssche, Mark A. Goldsmith, Zhengping Wang, Adrian L. Gill, (unknown)	1
5	Abstract 2837: Dual inhibition of SHP2 and CDK4/6 leads to immunological memory and immune-mediated anti-tumor activity in a mouse syngeneic model of breast cancer 2020 ·Cancer Research ·Nataliya Tovbis Shifrin, Grace J. Lee, (unknown), (unknown), (unknown), Edward Lorenzana, Robert J. Nichols, Jacqueline A.M. Smith, Mallika Singh, Elsa Quintana	2
6	Abstract PR10: Tri-complex inhibitors of the oncogenic, GTP-bound form of KRASG12C overcome RTK-mediated escape mechanisms and drive tumor regressions in vivo 2019 ·Molecular Cancer Therapeutics ·Christopher J. Schulze, Alun Bermingham, Tiffany J. Choy, (unknown), Gert Kiss, Abby Marquez, (unknown), (unknown), Caroline E. Weller, Daniel M. Whalen, Yu Chi Yang, Elena S. Koltun, Robert J. Nichols, Mallika Singh, David Wildes, Adrian L. Gill, Richard L. Hansen, (unknown), Mark A. Goldsmith, Jacqueline A.M. Smith	15
7	Abstract B108: 4EBP3 mRNA as a biomarker of therapeutic response to treatment with mTORC1 inhibitors 2019 ·Molecular Cancer Therapeutics ·Bianca J. Lee, Nuntana Dinglasan, (unknown), (unknown), (unknown), G. Leslie Burnett, James B. Aggen, Robert J. Nichols, Mallika Singh, David Wildes, (unknown)	0
8	Abstract A103: Allosteric inhibition of SHP2 induces antitumor immunity in PD-1-sensitive tumors through modulation of both innate and adaptive mechanisms 2019 ·Cancer Immunology Research ·Elsa Quintana, Kasia Mordec, Robert J. Nichols, David Wildes, (unknown), Darienne R. Myers, Mallika Singh, Elena S. Koltun, Adrian L. Gill, Stephen M. Kelsey, Mark A. Goldsmith, (unknown)	1
9	Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins 2018 ·Cancer Research ·Dana S. Neel, (unknown), Victor Olivas, Manasi K. Mayekar, Golzar Hemmati, Nilanjana Chatterjee, Collin M. Blakely, Caroline E. McCoach, Julia Rotow, Anh T. Le, Niki Karachaliou, Rafael Rosell, Jonathan W. Riess, Robert J. Nichols, Robert C. Doebele, Trever G. Bivona	63
10	Abstract 4877: Allosteric inhibition of SHP2 variants containing cancer-associated activating mutations 2018 ·Cancer Research ·David Wildes, Naing Aay, (unknown), (unknown), Ashutosh S. Jogalekar, Gert Kiss, Elena S. Koltun, Abby Marquez, (unknown), Jason M. Romero, (unknown), Christopher J. Schulze, (unknown), (unknown), Robert J. Nichols, Carlos Stahlhut, Christos Tzitzilonis, Adrian L. Gill, Jacqueline A.M. Smith	1
11	Abstract 4878: RMC-4550, an allosteric inhibitor of SHP2: Synthesis, structure, and anti-tumor activity 2018 ·Cancer Research ·Elena S. Koltun, Naing Aay, (unknown), Ashutosh S. Jogalekar, Gert Kiss, Abby Marquez, (unknown), Kasia Mordec, (unknown), (unknown), Nidhi Tibrewal, Christos Tzitzilonis, (unknown), Jacqueline A.M. Smith, Susan E. Wilson, Robert J. Nichols, Zhengping Wang, (unknown), Mallika Singh, Adrian L. Gill	8
12	CC-401 Promotes β-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition 2018 ·Endocrinology ·(unknown), Zhengshan Zhao, Sooyeon Lee, Haixia Xu, (unknown), Timothy M. Horton, (unknown), (unknown), Robert J. Nichols, David McCutcheon, Aryaman Shalizi, Mark Smith, N. Armstrong, Justin P. Annes	51
13	Abstract 3993: Efficacy of SHP2 phosphatase inhibition in cancers with nucleotide-cycling oncogenic RAS, NF1 loss and RAS-GTP-dependent oncogenic BRAF 2018 ·Cancer Research ·Trever G. Bivona, Robert J. Nichols, Franziska Haderk, Carlos Stahlhut, Christopher J. Schulze, Golzar Hemmati, David Wildes	1
14	Adult tissue sources for new β cells 2013 ·Translational research ·Robert J. Nichols, (unknown), Justin P. Annes	10
15	Biotype Designations and Insecticide Susceptibility of Southwestern Bemisia tabaci 2007 ·UA Campus Repository (The University of Arizona) ·Timothy J. Dennehy, Benjamin A. Degain, Virginia S. Harpold, Robert J. Nichols	6
16	Mechanistic Studies of R67 Dihydrofolate Reductase 1997 ·Journal of Biological Chemistry ·Heonyong Park, Ping Zhuang, Robert J. Nichols, Elizabeth E. Howell	25
17	Tyrosine kinase activity in Pseudomonas aeruginosa 1994 ·Molecular Microbiology ·(unknown), Robert J. Nichols, Thomas C. Montie	15
18	Titration of histidine 62 in R67 dihydrofolate reductase is linked to a tetramer .tautm. two-dimer equilibrium 1993 ·Biochemistry ·Robert J. Nichols, C. David Weaver, Edward Eisenstein, Raymond L. Blakley, James R. Appleman, (unknown), (unknown), Elizabeth E. Howell	27
19	Does R67 Dihydrofolate Reductase Possess a Proton Donor? 1993 ·Advances in experimental medicine and biology ·(unknown), Charles E. Linn, Enrico L. DiGiammarino, Robert J. Nichols, Elizabeth E. Howell	3
20	Construction of a synthetic gene for an R-plasmid-encoded dihydrofolate reductase and studies on the role of the N-terminus in the protein 1991 ·Biochemistry ·(unknown), Robert J. Nichols, Richard C. Ogden, Elizabeth E. Howell	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact